Amanote Research
Register
Sign In
07 Identifying and Prognosticating Malignant Brain Tumors Non-Invasively Using Unique Metabolomic Signatures Derived From Patient Serum and Urine Samples
Canadian Journal of Neurological Sciences
- United Kingdom
doi 10.1017/cjn.2018.299
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Neurology
Date
June 1, 2018
Authors
D Yusuf
AD Singh
R Shaykhutdinov
J Wen
P Forsyth
HJ Vogel
JG Cairncross
AM Weljie
JC Easaw
Publisher
Cambridge University Press (CUP)
Related search
Scaled Traumatic Brain Injury Results in Unique Metabolomic Signatures Between Gray Matter, White Matter, and Serum in a Piglet Model
PLoS ONE
Multidisciplinary
Imaging Microglia and Astrocytes Non-Invasively Using Diffusion MRI
Metabolomic Profiling of Urine Samples From Mice Exposed to Protons Reveals Radiation Quality and Dose Specific Differences
Radiation Research
Nuclear Medicine
Radiology
Radiation
Imaging
Biophysics
Non-Malignant Cardiac Tumors
Local Treatment of Malignant Brain Tumors Using Implantable Chemotherapeutic Polymers
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Quantitative Single Cell Heterogeneity Profiling of Patient Derived Tumor Initiating Gliomaspheres Reveals Unique Signatures of Malignancy and Response
Targeting Malignant Brain Tumors With Antibodies
Frontiers in Immunology
Allergy
Immunology
Using MRI to Non-Invasively and Accurately Quantify Preoperative Hepatic Steatosis
HPB
Hepatology
Gastroenterology
H-NMR Based Serum Metabolomic Signatures Imperative in Retinalneurodegeneration and Development of Diabetic Retinopathy
International Journal of Medical Research and Review
